🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.760
-0.060 (-2.13%)
At close: Nov 19, 2026, 4:00 PM EST
2.630
-0.130 (-4.71%)
After-hours: Nov 19, 2026, 6:19 PM EST

OnKure Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
11239115--
Market Cap Growth
181.61%-65.75%---
Enterprise Value
-51-30243--
Last Close Price
2.762.908.60--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.710.701.11--
P/TBV Ratio
0.710.701.11--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.010.020.06
Net Debt / Equity Ratio
-1.03-1.04-1.06-1.04-1.09
Net Debt / EBITDA Ratio
2.480.942.070.800.37
Net Debt / FCF Ratio
3.391.132.140.840.39
Quick Ratio
18.589.9710.524.102.08
Current Ratio
18.8410.2810.734.642.46
Return on Equity (ROE)
-55.18%-74.39%-79.92%-186.07%-
Return on Assets (ROA)
-34.38%-44.45%-44.43%-89.24%-
Return on Capital Employed (ROCE)
-41.70%-112.00%-51.30%-129.80%-284.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-70.32%-151.48%-45.91%--
FCF Yield
-42.88%-132.03%-44.60%--
Buyback Yield / Dilution
-139.12%-292.10%-1114.54%--
SEC Filings: 10-K · 10-Q